Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT01111786
Thirty subjects with systemic sclerosis and 30 age and sex matched controls without any known condition that should cause increased skin hardness in the fingers with undergo examination by manual palpation and durometer measured hardness of their digital tuft skin by 2 observers on 2 separate occasions. There will be 1 hour between individual observer's scorings. Observers will be blinded from the observer's scores and from their previous scores. Results will be tabulated and compared for manual scores versus durometer measurements, intra-observer scores by both methods and inter-observer scores by both methods.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
It is pretty straightforward. We will measure and record the hardness of the digital tufts on ten digits by palpation and the hardness in the same area by using a durometer. We will repeat this one hour later. Scores will be compared as a measure of how consistent and precise they are.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 1 year
Two investigators will compare data from 30 patients with scleroderma and 30 control patients without fingertip inflammation or tightness twice using durometer readings to those done by manual palpation.
Mayo Clinic
Other
Durometer Skin Assessment in Scleroderma: a Study to Validate This New Tool in the Digital Tufts
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03222492
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis
Los Angeles, California, United States
View Trial DetailsNCT05204355
Connective Tissue Diseases, Scleroderma
Kansas City, Kansas, United States
View Trial DetailsNCT05995626
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Omaha, Nebraska, United States
View Trial DetailsNCT03207997
Connective Tissue Diseases, Fibrosis
Paris, France
View Trial Details